As of 2025-07-15, the Relative Valuation of Sorrento Therapeutics Inc (SRNE) is (3,988.76) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.31 USD, the upside of Sorrento Therapeutics Inc based on Relative Valuation is -1298101.0%.
The range of the Relative Valuation is (2,876.13) - (4,713.67) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 11.8x - 23.9x | 18.2x |
Forward P/E multiples | 12.2x - 20.1x | 15.8x |
Fair Price | (2,876.13) - (4,713.67) | (3,988.76) |
Upside | -936037.1% - -1533996.9% | -1298101.0% |
Date | P/E |
2025-07-14 | -0.00 |
2025-07-11 | -0.00 |
2025-07-10 | -0.00 |
2025-07-09 | -0.00 |
2025-07-08 | -0.00 |
2025-07-07 | -0.00 |
2025-07-03 | -0.00 |
2025-07-02 | -0.00 |
2025-07-01 | -0.00 |
2025-06-30 | -0.00 |
2025-06-27 | -0.00 |
2025-06-26 | -0.00 |
2025-06-25 | -0.00 |
2025-06-24 | -0.00 |
2025-06-23 | -0.00 |
2025-06-20 | -0.00 |
2025-06-18 | -0.00 |
2025-06-17 | -0.00 |
2025-06-16 | -0.00 |
2025-06-13 | -0.00 |
2025-06-12 | -0.00 |
2025-06-11 | -0.00 |
2025-06-10 | -0.00 |
2025-06-09 | -0.00 |
2025-06-06 | -0.00 |
2025-06-05 | -0.00 |
2025-06-04 | -0.00 |
2025-06-03 | -0.00 |
2025-06-02 | -0.00 |
2025-05-30 | -0.00 |
2025-05-29 | -0.00 |
2025-05-28 | -0.00 |
2025-05-27 | -0.00 |
2025-05-23 | -0.00 |
2025-05-22 | -0.00 |
2025-05-21 | -0.00 |
2025-05-20 | -0.00 |
2025-05-19 | -0.00 |
2025-05-16 | -0.00 |
2025-05-15 | -0.00 |
2025-05-14 | -0.00 |
2025-05-13 | -0.00 |
2025-05-12 | -0.00 |
2025-05-09 | -0.00 |
2025-05-08 | -0.00 |
2025-05-07 | -0.00 |
2025-05-06 | -0.00 |
2025-05-05 | -0.00 |
2025-05-02 | -0.00 |
2025-05-01 | -0.00 |